Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.05%

Navidea Biopharmaceuticals, Inc (NAVB)

-NYSE MKT
1.32 0.02(1.49%) Jul 29, 4:01PM EDT
Prev Close:1.34
Open:1.34
Bid:1.30 x 300
Ask:1.84 x 3000
1y Target Est:2.81
Beta:0.92
Next Earnings Date: 6-Aug-14NAVB Earnings announcement
Day's Range:1.32 - 1.34
52wk Range:1.11 - 3.15
Volume:360,478
Avg Vol (3m):987,376
Market Cap:196.99M
P/E (ttm):N/A
EPS (ttm):-0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NAVB

Comparison

Symbol% ChgMkt Cap
NAVBDown 1.49%196.99M
LLY67.57B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):106.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.27
Quarterly EPS Est (Jun-14) :-0.07
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback